Blog Read the latest perspectives from our team of subject matter experts and others How H1 Integrates with Your CRM of ChoiceAt H1, we know that every life sciences organization has unique needs when it comes to customer relationship management (CRM). Some companies rely on long-established platforms, while others are adopting… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact KOL Engagement Patient Representation Provider Data Post Industries:Digital Health Health Plans Pharmaceutical & Biotechnology KOL EngagementPayer Mix: Understanding How Patients Receive Care and Who Pays for itTo find out which healthcare providers (HCPs) are actively treating patients in a therapeutic area, you’ll want access to more than just publication information. To really dig in, you… Continue reading → Read the article KOL EngagementAnnouncing A New Way to Identify KOLs with Claims DataPublications can only get you so far. If your medical affairs team really wants to know who’s actively treating patients in a therapeutic area, you need access to claims data.… Continue reading → Read the article KOL EngagementThe Importance of an Integrated KOL Engagement StrategyBuilding long-term, mutually beneficial relationships with external stakeholders such as physicians, key opinion leaders (KOLs) and other experts is the ultimate goal of medical affairs, specifically medical science liaisons (MSLs).… Continue reading → Read the article CommercializationMedical Nanotechnology: What’s Real & What’s NotSince Elon Musk’s tweet characterizing nanotech as “BS,” there’s been a continuing debate about the practical applications of nanotechnology — and where the dividing line between innovation and hype lies. Medical nanotechnology,… Continue reading → Read the article KOL Engagement5 Daily Challenges of MSLsThe job of an MSL is not for the faint of heart: an exciting job for scientists or medical doctors, being an MSL is not without a set of challenges.… Continue reading → Read the article Drug DevelopmentKOL EngagementThe Future of Medical AffairsIt is not the first time we say this: healthcare is rapidly changing and is driven by several different factors, chief among them our ability to create ever-increasing amounts… Continue reading → Read the article«‹12131415161718›»
